Codigo46

Codigo46 is a Mexican biotechnology company specializing in pharmacogenomics and personalized medicine. The company provides comprehensive genetic testing services designed to help healthcare providers optimize drug therapy based on a patient's unique genetic makeup. By utilizing advanced sequencing technologies from partners like Illumina, Codigo46 delivers actionable insights regarding drug metabolism, potential adverse reactions, and hereditary health predispositions. Their platform aims to integrate genomic data into clinical decision-making to improve patient safety and treatment efficacy across Latin America. The company was notably the first Mexican startup to be selected for the Illumina Accelerator program.